Express Pharma Sign Up Information

Every innovation has to benefit mankind at large

Chakravarthi AVPS, Global Ambassador, World Packaging Organisation shares insights about the emerging trends in pharma packaging,? growing role and importance of this function in driving important gains and benefits such as patient-centricity, and measures to insulate the packaging industry from disruptions like the COVID-19 in future, in an interview with Usha Sharma?

Chinese researchers launch phase-2 human test for possible coronavirus vaccine

IMBCAMS began a phase 2 human test for its experimental shot, which is among six possible vaccines Chinese scientists are testing in humans, following an on-going phase-1 study that has recruited about 200 participants since May

Cipla launches remdesivir under brand name CIPREMI

The product will be in the form of lyophilised powder for injection 100 mg

DKSH to commercialise seven generic formulations of Biocon Pharma in Singapore and Thailand

The formulations belong to various therapeutic areas like diabetology, cardiology, oncology and immunology

Intravacc's experimental whooping cough vaccine shows promising results in a preclinical study

The study shows that intranasal immunization induced both excellent systemic and local immune responses, but also prevented colonization of the lung, trachea and nose

Alembic Pharma gets tentative US FDA nod for generic Rivaroxaban tablets

The tablet is the generic of Janssen Pharmaceuticals’s reference listed drug product Xarelto

Merck and 10x Genomics launch new option for CRISPR research

The companies will work together as part of 10x Genomics' 10x Compatible Partnership Program, a global ecosystem of technologies and solutions that provide customers with the ability to enhance their unique research applications and accelerate discovery

COVID-19 expedites India's focus on innovation within pharma: GlobalData?

According to the Global Innovation Index, India has moved up four places to 48 in the overall ranking across sectors in 2020

LogiNext launches COVID-19 vaccine supply chain management platform

The solution can be used for the entire chain or a part of the solution can be used?for visibility and tracking, demand forecasting and order scheduling and detailed analytics

Himalaya study finds herbal immunomodulators effective as adjuvant treatment for COVID-19

The study states that adjuvant therapy with Septilin and Bresol along with SOC supports immunity and controls inflammation in COVID-19-positive patients and helps in?the recovery of symptoms of post-COVID-19 illness

Biocon Biologics signs MoU with CSSC in Tanzania for Mission 10 cents, affordable insulins programme

The programme is expected to roll-out early next year

EQT makes $2.8 bn bid for Recipharm

EQT said it was bidding 220 crowns per Recipharm share, a 22.9 per cent premium to Recipharm's closing price

Sputnik V vaccine efficacy is 91.4 per cent: RDIF, Gamaleya Center

Based on the data obtained at the third control point, the Gamaleya Center will create a report that will be used to submit for accelerated registration of the Sputnik V vaccine in various countries

Career prospects in pharma in the new normal

The pharma sector is moving from being traditional to a highly technology-driven one, highlights Sanjeev Goel, Business Head, Manipal ProLearn as he explains that the roles in the pharma industry are transforming and outlines the growth prospects for people choosing to work in this sector

Digital marketing should continue post-COVID-19: Experts

It reduces expenditure, provides targeted better returns

Russia registers first COVID-19 vaccine, President Putin's daughter given a shot

Putin said that it works quite effectively, forms strong immunity and has passed all the needed checks

Gilead seeks full approval for remdesivir from US FDA for COVID-19 treatment

To boost the drug's availability globally, Gilead has signed multiple manufacturing and supply deals, including with Pfizer and Britain's Hikma Pharmaceuticals

UK-India experts' drive to stop antibiotic waste creating more 'superbugs'

The project is part of ?8 million package of UK-India government-backed research which also comprises programmes to tackle AMR?????????????????

Lupin launches Zileuton extended-release tablets

This tablet is indicated for the prophylaxis and chronic treatment of asthma in adults and children 12 years of age and older

IIT Mandi team compares disordered proteins in COVID-19 virus through computational studies

Understanding the structure and functions of intrinsically disordered proteins (IDPs), and intrinsically disordered protein regions (IDPR) in COVD-19 can help in finding ways to mitigate the effects of the infection, say researchers

OTC healthcare products: A growth area for India Pharma Inc

Dr Atish Rodge, MD & Founder, Allmpus Laboratories points out that India is an increase in demand for OTC healthcare products and informs that increasing health expenditure due to the pandemic, a sudden rise in lifestyle diseases, and India’s massive population makes this segment a promising market for the future

Wave of promising study results raises hopes for coronavirus vaccines

Whether any of these efforts will result in a vaccine capable of protecting billions of people and ending the global pandemic that has claimed more than 600,000 lives is still far from clear

Six people tests coronavirus positive in Maha FDA

A majority of them contracted the virus during field visits

Govt may allow 30 per cent import of chemicals/intermediates in PLI scheme

In the next phase of the PLI scheme, the government has plans to incentivise excipient manufacturers

FabiFlu more affordable than other drugs: Glenmark to DCGI

The company also sends its justifications and clarifications to allegations of false claims about FabiFlu's use for COVID-19 patients

Biocon Biologics and Voluntis collaborate on digital therapeutics for insulins

Insulia is the first digital therapeutic with regulatory clearance to provide automated titration recommendations for all types of basal insulins

Over 158 applications for generic products pending with US FDA for approval: Lupin

Sharing information with company’s shareholders, Lupin MD Nilesh Gupta and CEO Vinita Gupta said the company’s US business stabilised last fiscal and saw an increase of 5 per cent on the back of products like Levothyroxine and Oseltamivir

J&J COVID-19 vaccine trial paused due to unexplained illness in participant

The participant’s illness is being reviewed and evaluated by an independent data and safety monitoring board, as well as the company’s clinical and safety physicians, informed J&J

Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size

For the past two decades, single-use disposable autoinjectors have become the predominant drug delivery device to treat immunosuppressive and inflammatory diseases, and a range of other health conditions. Autoinjectors have evolved to become more compact, reliable, and easy to use; however, these devices also possess certain suboptimal characteristics associated with single-use products. New innovations can now overcome the challenges of traditional disposable autoinjector technology, while providing a proven platform for pharmaceutical companies.

Read More

HitGen to acquire Vernalis for $25 mn in cash

The closing of this transaction is subject to customary conditions and approvals, expected to complete before the end of 2020

Sun Pharma, Strides Pharma recall drugs in the US

Sun Pharma is recalling 747 bottles of generic diabetes drug due to higher levels of NDMA while Strides Pharma is recalling 11,280 bottles of potassium chloride extended-release tablets due to failed dissolution specifications

UK to commence anti-TB BCG vaccine trials to test efficacy against COVID-19

Previous studies suggest that the BCG vaccine could reduce susceptibility to a range of infections caused by viruses including those similar to the novel coronavirus causing COVID-19

Choosing the right type of desiccant is quintessential for your product's shelf life

CILICANT understands how critical it is to choose the right desiccant and offers a variety of sorbents developed for different applications

Innovation - The next frontier

Alok Ghosh, Ex-President – Global Technical Operations, Lupin, underscores the importance of creating a conducive environment to foster innovation in India's life sciences sector to ensure its continuous progress

COVID-19 vaccine will not be made mandatory: Joe Biden

Biden said he is willing to get inoculated in public to assuage any concerns about the vaccines' efficacy and safety

A large basket of COVID-19 vaccine candidates is important: Renu Swarup

She said the vaccines that are being developed indigenously are on different platforms and each has its own benefits and challenges

Regenerative medicine market to reach $16.4 bn in 2026: GlobalData

There are currently 53 marketed RM products and 175 RM pipeline agents in development in the eight major markets

Indifi forays into pharma segment along with Marg ERP

Indifi will be extending its credit line solution to pharma distributors and local chemists for managing their working capital needs and cash flows using the Margpay platform

Zydus gets DCGI approval to commence Phase III clinical trials with Pegylated Interferon alpha-2b

In Phase II clinical trials, Pegylated Interferon alpha - 2b increased viral reduction and reduced the need for supplemental oxygen in moderate COVID-19 patients

Rising trends in combination drugs markets?

Apurve Mehra, Founder, Biogetica opines that natural medicine can serve as an effective adjunct for almost every single ailment and health interest

Three big-ticket deals contributed 69 per cent of total deal value in November 2020

The healthcare industry reported 91 VC deals worth $3.3 billion in November 2020

JNU researchers develop new drug molecules to can act against amoebiasis

Entamoeba expresses two crucial enzymes for synthesising cysteine and researchers from JNU have, reportedly, characterised and determined the molecular structures of both these enzymes

Remdesivir, tocilizumab and CPT included in revised protocols for COVID-19 clinical management

Hydroxychloroquine can be prescribed in the early stages of COVID-19 infection but not for patients with severe disease, use of azithromycin has been discontinued

Sun Pharma presents clinical insights of ODOMZO and LEVULAN KERASTICK + BLU-U Data for skin cancer treatment

Analyses of long-term data confirm that the continued and clinically meaningful results of ODOMZO?(sonidegib)?in people with locally advanced basal cell carcinoma (laBCC) are not impacted by concomitant medicines.

BDR Pharma urges regulators to expedite manufacturing, marketing license process for remdesivir

The company informed that central and state regulatory authorities have carried out an inspection of its API manufacturing site in Vadodara, formulation facility likely to get inspected

Lupin ties up with Omron Healthcare

To strengthen respiratory disease management facilities Medical device maker Omron Healthcare India has joined hands with pharma firm Lupin to strengthen respiratory disease management facilities, focussing on asthma and chronic obstructive pulmonary disease patients. The alliance aims to support the whole journey and experience of a respiratory patient right from diagnosis to treatment, […]

Cancer CART therapy: What are the benefits and stakes?

Debamita Chatterjee, Ex-researcher, Harvard Medical School and NYAS/MIT/European Commission Innovation Mentor elaborates how R&D, regulatory and commercial activities have globally bolstered the technological promise of Cancer CART therapy, and outlines its progress and adoption in India

Merck to unveil its latest innovation during Live Virtual Launch on June 18

Redesigns its Benchtop Pure Water Solution - the Milli-Q? IX Pure Water Purification System

PCI to revamp Pharm D curriculum

Plans to release draft for comments and suggestions by the end of October 2020

COVID-19 vaccine makers to prepare joint pledge for safety

The companies would pledge to adhere to high scientific and ethical standards in the conduct of clinical studies and in their manufacturing processes

Lilly gets US FDA nod for additional doses of Trulicity (dulaglutide) to treat type 2 diabetes

The approval expands the label of once-weekly Trulicity to include 3.0 mg and 4.5 mg doses based on data from AWARD-11 trial

Sanofi impacted by disrupted clinical trials and lagging vaccine development due to COVID-19: GlobalData

Six of Sanofi's clinical trials, which were being conducted in 31 countries, have been disrupted, which might impact the company’s regulatory decisions

Fighting fakes with technology

Vinod Kumar Arora,?Principal Advisor, Institute of Good Manufacturing Practices India (IGMPI) states that the time has come when all packs sold in India are encrypted, coded and the data is available at the CDSCO server to fight to counterfeits

Three major deals contributed 74 per cent of deal value in August 2020

Deal value in the M&A market reported a surge in this month, as per a GlobalData report

To accelerate recovery of pharma ancillary industry, primary focus should be financial relief to players

Rishabh Bindlish, MD, Life Sciences and Global Generics Lead, Accenture in India talks about the measures needed to revive the pharma ancillary industry and make it more risk-proof, in an exclusive interaction with Tarannum Rana

More than APIs, Indian pharma industry needs to reduce dependency on drug intermediates: Premchand Godha

Policies, schemes should be designed keeping overall drug industry in mind, said the Chairman and MD of Ipca Laboratories

Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size

For the past two decades, single-use disposable autoinjectors have become the predominant drug delivery device to treat immunosuppressive and inflammatory diseases, and a range of other health conditions. Autoinjectors have evolved to become more compact, reliable, and easy to use; however, these devices also possess certain suboptimal characteristics associated with single-use products. New innovations can now overcome the challenges of traditional disposable autoinjector technology, while providing a proven platform for pharmaceutical companies.

Read More

US FDA issues warning letter to Shilpa Medicare for Jadcherla facility, Telangana

The company believes that the warning letter will have minimum impact of disruption of supplies and the existing revenues from operations of this facility

Deal value in the M&A market decreased in Sept 2020 compared to $35.7 bn in Aug 2020

In September 2020, the healthcare industry reported 84 deals worth $28.2 billion as compared to the last 12-month average (September 2019 to August 2020) of 75 deals worth $11.6 billion. Deal value in the M&A market decreased in September 2020 compared to $35.7 billion in August 2020. Gilead Sciences to acquire Immunomedics, for […]

Vir Biotech research highlights mechanism to enhance monoclonal antibodies for inducing protective response

The research published in Nature focuses on the role of the Fc domain of monoclonal antibodies, regions with the capacity to bind to other immune cells through a family of receptors

Choosing the right type of desiccant is quintessential for your product's shelf life

CILICANT understands how critical it is to choose the right desiccant and offers a variety of sorbents developed for different applications

Beyond highly developed pharma markets! Wild card access to less explored, high entry barrier territories

Sameer Kolhe, President, Maypharm Life Sciences highlights that COVID-19 brings some 'challenging' markets within reach for the Indian pharma manufacturers

Bharat Biotech gets green signal from CDSCO to test COVAXIN via skin

Presently, the vaccine is being tested through the intramuscular route

US pharma firm, Advanced Penetration Technology tests FDA-approved ointment to treat COVID-19

A research concludes that APT T3X effectively neutralises viral infectivity within seconds and its topical intranasal use can decrease the viral load of exposure.

NPPA fixes retail prices of 30 formulations, rejects four applications

Two applications each of Micro Laboratories and Sun Pharma have been deferred by the authority

Panacea Biotec terminates MoU with Refana for COVID-19 vaccine

The company informed that the termination is due to delays in project timelines and difficulty in moving ahead with the joint venture

US FDA approves Novartis Kesimpta (ofatumumab) for relapsing forms of MS treatment

Ofatumumab was first approved by the FDA in 2009 for the treatment of chronic lymphocytic leukaemia (CLL)

How robots are lending a hand with healthcare, medical devices and pharma worldwide

From pharma and medical device production to medical and research laboratories, the latest robotics solutions can support the human workforce and transform the quality, capacity and cost of operations, informs Subrata Karmakar, President – Head of Robotics & Discrete Automation Business, India at ABB India

Stempeutics’ allogeneic cell therapy gets DCGI approval, Cipla to market and distribute Stempeucel

Indicated for the treatment of CLI due to Buerger's Disease and Atherosclerotic Peripheral Arterial Disease, it is the first allogeneic cell therapy product to be approved for commercial use in India

Bharat Biotech starts human trials for Covaxin, India’s first COVID-19 vaccine

The company had earlier received approval from the Drug Controller General of India (DCGI) to conduct phase I and II human clinical trials

Cipla receives final approval for generic version of Shire's Firazyr

Icatibant injection is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older

Biocon to launch drug for COVID-19 patients; priced at Rs 8,000 per vial

Itolizumab is the first novel biologic therapy to be approved anywhere in the world for treating patients with moderate to severe COVID-19 complications, Biocon had earlier said in a regulatory filing

DoP to finalise guidelines to select locations of three bulk drug parks and four med devices parks: Gowda

Govt of Punjab shows interest in extending support for the development of bulk drugs park in the State

Pfizer, BioNTech’s coronavirus vaccine candidates get US FDA’s ‘fast track’ status

The market is "desperate to latch onto any positive developments in the vaccine field," JP Morgan analyst Cory Kasimov said in a note

Institute of Life Sciences, Odisha establishes in vitro cultures of COVID-19

This could help to identify drug targets, formulations for the treatment of COVID-19

Bharat Biotech gets DCGI nod for PHASE II trials of COVAXIN

The subject expert committee (SEC) has recommended that the trial will be conducted on 380 participants

E-pharma set to revolutionise drug market access in India: GlobalData

E-pharma companies will offer competitive pricing and access to quality medicines even in remote places along with the ease of consultation

India ramping up API manufacturing: NITI Aayog CEO

The Indian government is committed to achieving its ”Pharma Vision 2020”, which aims to make the country a global leader in drug discovery, innovation, and drug manufacturing, said Kant

UPSIDA organises webinar to attract investors for proposed bulk drug park in Lalitpur

State authorities highlight initiatives that will be taken to create advantages for investors; stakeholders recommend measures to increase ease of doing business and maximise opportunities

Hamdard Labs starts clinical trials of two drugs to evaluate efficacy to prevent COVID-19 infection

After regulatory approval from AYUSH ministry, the clinical trials are being conducted at HAH Centenary Hospital, New Delhi

Mylan to acquire thrombosis business in Europe from Aspen Pharmacare for EUR 641.9 mn

Transaction expected to be immediately accretive to Mylan upon closing and is anticipated to be accretive to VIATRIS

BPPI records sales turnover of Rs 146.59 cr in first quarter of 2020-21

The total sales up to July 31, 2020, stood at Rs 191.90 crores

Novavax expands deal with Serum Institute, aims for two billion COVID-19 vaccine doses

Serum Institute will also manufacture the antigen component of the vaccine, dubbed NVX-CoV2373

Saptagir Labs signs manufacturing deal with Jubilant Generics for remdesivir

The drug will be produced at its sterile drug product manufacturing plant in Hyderabad which is WHO GMP certified

Strides to invest Rs 1350 mn in 24 months in SteriScience, sterile injectables arm

SteriScience expects the first ANDA filing to be achieved within FY21

We are prepared to take on significant volumes from pharma partners working on COVID-19 vaccines

Megan Williamson, Head of Sales, Americas Datwyler elaborates how Datwyler is gearing up to meet the requirements of pharma companies developing COVID-19 vaccines across the globe. She also talks about the company's business strategies and plans for the future, in an interaction with Usha Sharma

Top 20 global pharma companies by MCap saw 10.2 per cent rise in MCap in Q2 2020: GlobalData

Johnson & Johnson maintained its top position with MCap growth of 7.2 per cent on a QoQ basis

Baricitinib in combination with remdesivir reduces recovery time in hospitalised COVID-19 patients: Study

Data from the Adaptive COVID-19 Treatment Trial (ACTT-2) revealed an approximately one-day reduction in median recovery time for the overall patient population

Why pharma industry needs to focus more on training

Subrata Chakraborty, Senior Director – Technical Services, Cipla informs that investing in a robust learning management programme led by qualified and competent professionals is an immutable need for the pharma and biotech industry

Sinovac’s COVID-19 vaccine candidate get emergency use approval in China

China has also approved the use of CanSino Biologics' vaccine candidate

Govt may consider amendments in PLI scheme, submit recommendations: Dr Eswara Reddy

He asks associations to submit recommendations with scientific?evidence for further discussion with the concerned authorities in DoP

GARDP and Bugworks sign MoU to develop antibiotics for serious bacterial infections

The collaboration includes working together for the preparation of regulatory strategies, in particular for clinical development programmes and post-approval studies

Cadila Pharma launches Cadalimab (adalimumab biosimilar) for India

It is used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and psoriasis

India's proposed new agile pharma regulations will benefit innovator companies: GlobalData

This could mean accelerated access of multiple novel therapies and vaccines for Indian patients

Sometimes giants need a shoulder to stand on too

Clarinda Cerejo, VP, Content & Community, CACTUS highlights that it is time to create a more conducive environment for researchers with better management and administrative support, more open acknowledgement and discussion of failures, better training for non-research responsibilities, and easily accessible support systems?

Piramal Pharma Solutions to join hands with Epirium Bio to develop and manufacture orphan drugs

The integrated programme, involving three Piramal Pharma Solutions sites, encompasses formulation development, supply of APIs and intermediates, chemistry development and manufacturing, and solid oral dosage form drug product

PNB Vesper to commence phase II clinical trial of COVID-19 drug in?BJ Medical College, Pune

The company has already patented the molecule and secured intellectual property rights in the US, Europe and rest of the world

Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size

For the past two decades, single-use disposable autoinjectors have become the predominant drug delivery device to treat immunosuppressive and inflammatory diseases, and a range of other health conditions. Autoinjectors have evolved to become more compact, reliable, and easy to use; however, these devices also possess certain suboptimal characteristics associated with single-use products. New innovations can now overcome the challenges of traditional disposable autoinjector technology, while providing a proven platform for pharmaceutical companies.

Read More

Canada to invest up to C$214 mn for R&D of home grown COVID-19 vaccines: Trudeau

It has secured up to 76 million doses of Quebec City-based Medicago's potential vaccine

DPX-COVID-19 has potential to improve duration of immune response

Frederic Ors, CEO, IMV explains why the company believes that?DPX-COVID-19 has the potential to improve the duration of the immune response and protect older?adults and more vulnerable individuals from SARS-COV-2 infection, in an interaction with?Viveka Roychowdhury ?

Bharat Biotech in talks with many countries for clinical trials, manufacture of COVAXIN

The countries are located in South America, Asia and Central Asia, and Eastern Europe

Arixa Pharma to be acquired by Pfizer's Hospital Business

Pfizer to develop ARX-1796 which, if approved, has potential to be the first novel oral beta-lactamase inhibitor + antibiotic combination in more than 35 years

Mental health drugs market: Assessing the growth potential

Philippa Salter, Healthcare Analyst, GlobalData points out that any novel therapies and drugs that can tackle treatment-resistant patients will have a huge impact on the mental health drugs market

Brazil signs agreement to produce AstraZeneca’s COVID-19 vaccine candidate

The country will initially produce some 30 million doses of the vaccine

Key pipeline advancements to propel myelodysplastic syndromes market to $2.4 bn by 2028: GlobalData

Despite the recent surge of development within the MDS space, KOLs argue that the level of unmet need remained dire.

NRI professor discovers new therapy for epilepsy brain disease

This invention has clinical implications that could lead to the eventual treatment of uncontrolled seizures and epilepsy brain disease.

Study identifies immune cells involved in protection against COVID-19

It may lead to new vaccine development strategies against COVID-19

Carlyle Group to acquire 20 per cent stake in Piramal Pharma

The transaction worth $490 million is expected to close in 2020, subject to customary closing conditions and regulatory approvals Piramal Enterprises and The Carlyle Group announced that CA Clover Intermediate II Investments, an affiliated entity of CAP V Mauritius Limited, an investment fund managed and advised by affiliated entities of The Carlyle Group, […]

Tonix Pharmaceuticals and Southern Research COVID-19 vaccine provides a novel vector

As horsepox virus may have been accidentally extirpated there has most likely been no previous exposure to the vector, and any vaccine administered based on it is unlikely to encounter already-present neutralising antibodies

Understanding Virus and Viral Vaccine Development Using Multi Spectral Advanced Nano-Tracking Analyzer (NTA)

By Dr. Namrata Jain, Kanika Thakur, Dr. Jeffrey Bodycomb, Dr. Rajeev Gautam, Dr. John Kiran Anthony

India, China may start producing Sputnik V vaccine: Putin

Putin also proposed that the creation of a vaccine research centre for BRICS countries be sped up

T2D market will grow from a total of $48.1bn sales in 2019 to $91.9 bn in 2029

T2D market growth factors are increasing diagnosed prevalence of disease and the emergence of novel pipeline agents

Moderna, Pfizer raise bar for COVID-19 vaccines, may ward off competing candidates: GlobalData

While the most effective vaccines will ramp up production to meet global demand, the opportunity for less effective vaccines will wane

India is a key market for us, it is a pharma centre of excellence

Alessandra Vizza, Regional Business Director, Corning Reactor Technologies talks about Advanced-Flow Reactors (AFR) and explains how it can help Indian pharma companies upscale their production output by providing continuous process production capacity of up to hundreds of kilograms per hour, the company's plans for the Indian market and more, in interaction with?Lakshmipriya Nair

Bharat Biotech commences Phase III trials for COVAXIN?

Phase III trials will involve 26,000 volunteers across India who will receive two intramuscular injections, approximately 28 days apart

Catalent completes acquisition of Bone Therapeutics' cell therapy manufacturing subsidiary SCTS

The gross proceeds of the deal are ?12 million

Case Study: Sustainable, decentralised, waste management system

Dr Aparna Pandey, Head – Research wing, Monisha Narke , Founder and CEO and Pradnya Bandvdekar, Project Operations Executive, RUR GreenLife detail how the Bombay College of Pharmacy implemented an effective waste management system to reduce waste being transported to the landfills from their campus with technological consultation from RUR GreenLife

154 misleading ads related to AYUSH remedies for COVID-19 till August 2020: Dr Harsh Vardhan ?

Public advisories and guidelines issued for AYUSH remedies to treat COVID-19 infections, powers of regulation and quality control of these drugs and formulations are vested with the state governments

Phase III trials of Covishield vaccine in Pune next week

Around 150 to 200 volunteers will be administered the vaccine candidate dose

Life sciences companies revisiting their EU strategies want to understand the Irish proposition better

Tanaz Buhariwalla, India Director IDA Ireland talks about why Ireland is the next 'speak-to country' for India, post-Brexit for companies focussed on growing their European market, in an interview with Lakshmipriya Nair

Roche gets positive CHMP opinion for Tecentriq plus Avastin to treat liver cancer

The recommendation from the CHMP is based on results from the Phase III IMbrave150 study, which showed that Tecentriq in combination with Avastin reduced the risk of disease worsening or death

Indian pharma industry will be among the first to develop and supply low cost vaccines for COVID-19: Gowda

He also said that the bulk drug and medical device parks will attract cumulative investment of Rs 78000 crores

Developing herd immunity without pharma interventions may have detrimental consequences: Choubey

Thirteen clinical trials of repurposed drugs have been undertaken to build a portfolio of therapeutic options for COVID-19 patients, said the Minister

Why pharma industry needs to focus more on training

Subrata Chakraborty, Senior Director – Technical Services, Cipla informs that investing in a robust learning management programme led by qualified and competent professionals is an immutable need for the pharma and biotech industry

Clinical trials of AstraZeneca-Oxford COVID-19 vaccine candidate resumes in UK

This is following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so

COVAXIN demonstrates protective efficacy in animal studies: Bharat Biotech

A two-dose vaccination regimen, administered in 20 rhesus macques, showed increasing SARS-CoV-2 specific IgG and neutralizing antibodies, reducing replication of the virus in the nasal cavity, throat, and lung tissues

TN's industrial policy shall offer specific higher incentives for sunrise sectors

Dr Neeraj Mittal, MD & CEO, Guidance, Industries Department, Government of Tamil Nadu showcases how the State is an ideal investment destination for pharma and life sciences companies with a strategic location, conducive business ecosystem, advanced infrastructure and good governance, in an exclusive interaction with Lakshmipriya Nair

Gilead may soon buy Immunomedics in deal over $20 billion

The deal, which will expand Gilead's oncology portfolio, might get announced tomorrow if not sooner, inform reports

PNB Vesper gets DCGI nod to test proprietary drug PNB 001 in COVID-19 patients

A study will be conducted on 40 moderately-ill COVID-19 patients at BMJ Medical College, Pune who are on oxygen support

Pfizer and BioNTech submit proposal to US FDA to expand COVID-19 vaccine trial

The companies expect that a conclusive readout on efficacy is likely by the end of October

Global pharma's two battles - supply continuity and COVID-19 vaccine

Richa Mahindru, Domain Leader, Pharma and Life Sciences Practice, and Ishani Jain, Member, Pharma and Life Sciences Practice elaborate on how pharma companies are dealing with these twin challenges and point out that while global drug supply chains are shifting to local supply chains, vaccinology is moving at breakneck speed with vaccine development compressed into 12 months from a usual 12 years or so

Governments should work as a team for smooth, sustained COVID-19 vaccination drive: PM Modi

The PM said that any vaccine against coronavirus that is administered to citizens will meet all necessary scientific criteria

Micro Labs launches anti-diabetic drug combo, Dapagliflozin plus Metformin

The drug comes in two strengths ZUCAPRIDE-M 500 priced at Rs12.80 per tablet and ZUCAPRIDE-M 1000 at Rs 14.80

Sheffield University, Pfizer launch consortium for development of advanced therapy medicinal products

The ?25.5 milion project will help to fill the knowledge gaps in how advanced therapies could potentially work, and to develop appropriate standards to aid researchers, developers and regulators in accelerating effective and safe gene and cell therapies to benefit patients

Successive drug launches will drive growth of NASH market in seven major markets: GlobalData

The NASH market will undergo a very rapid growth, at a compound annual growth rate (CAGR) of 68.8 per cent from 2019 to 2029

AstraZeneca COVID-19 vaccine shows 90 per cent efficacy

AZD1222, given as a half dose, followed by a full dose at least one month apart, showed vaccine efficacy of 90 per cent while it showed 62 per cent efficacy when given as two full doses at least one month apart

Drug developers are interested in innovative polymers and multilayer technology to help meet packaging requirements

Rajarshi Datta, Country Head & General Manager – South Asia, Honeywell Advanced Materials informs there is a growing need for new packaging technologies that allow the pharma industry to launch drugs to market faster while reducing operational costs and shares details about Honeywell’s pharma packaging product offerings, in an interview with Lakshmipriya Nair

Reimagining the next era of doctor engagement

Rishabh Bindlish, MD, India Life Sciences and Global Generics Lead, Accenture in India explains that pharma companies need to re-evaluate their digital engagement for a seamless, consistent, intuitive and simplified customer experience

Hundreds of scientists say coronavirus is airborne, ask WHO to revise recommendations: NYT

The WHO has said the coronavirus disease spreads primarily from person to person through small droplets from the nose or mouth

ICMR defends COVID-19 vaccine deadline

In a statement, ICMR says that its process is in accordance with globally accepted norms to fast-track vaccine development for diseases of pandemic potential

Indian pharma firms recall medications from US market

Lupin and Marksans Pharma recall diabetes drugs while Alembic and Aurbindo recall medicines that treat mental disorders

Astrazeneca's Dapagliflozin gets DCGI nod for treatment of heart failure

Dapagliflozin (Forxiga) is an SGLT-2 inhibitor that can reduce the risk of cardiovascular death and hospitalisation for heart failure in patients with HFrEF

Stevioside can increase efficiency of cancer therapy using magnetic nano particles: Scientists

Coating nanoparticles with stevioside improved the cellular uptake of the nano-magnets in glioma C6 cancer cells and enhanced its retention time

Industry captains participate in consultation roundtable for STIP 2020

STIP 2020, expected to be released later this year, aims to re-strategise priorities, sectoral focus, and methods of research and technology development for larger socio-economic welfare

Emcure launches India first generic version of sucroferric oxyhydroxide for chronic kidney disease patients

Dynulta, the drug’s brand name, will be manufactured at Emcure’s state-of-the-art plant at Jammu and will be marketed at less than 70 per cent cost of the innovator brand

Inovio’s COVID-19 vaccine candidate shows promise in small early-stage trial

The vaccine induced immune responses in 34 of the 36 healthy volunteers aged 18 to 50 years, Inovio said

Researchers identify drugs that may block cell to cell transmission of coronavirus

The scientists analysed all host and viral proteins that showed changes in an enzymatic process called phosphorylation after SARS-CoV-2 infection

Pharma associations to make joint representation to govt over delay in custom clearance

Delay in custom clearance may lead to a shortage of medicines in the global pharma market, caution industry stakeholders

Experts recommend short-term, long-term measures for self-reliance

Recommended measures include alerting medical practitioners about a potential shortage of certain medicines and availability of alternative options, providing subsidies to industry, accelerating the implementation of announced schemes

Chinese researchers warn of new virus in pigs with human pandemic risk

A team of Chinese researchers looked at influenza viruses found in pigs from 2011 to 2018 and found a "G4" strain of H1N1 that has "all the essential hallmarks of a candidate pandemic virus"

Give details of COVID-19 ‘medicine’, stop advertising it: AYUSH ministry to Patanjali Ayurved

Ramdev’s herbal medicine company Patanjali Ayurved has launched ‘Coronil tablet and Swasari vati’ medicines claiming they can cure the highly contagious disease within seven days

Suven Life Sciences financial results – strong show in FY20; outlook upbeat: ICICI Securities

Net profit for FY20 was at Rs 317 crore with an NPM of 38.0 per cent

Understanding Virus and Viral Vaccine Development Using Multi Spectral Advanced Nano-Tracking Analyzer (NTA)

By Dr. Namrata Jain, Kanika Thakur, Dr. Jeffrey Bodycomb, Dr. Rajeev Gautam, Dr. John Kiran Anthony

Diabetes drug may lower COVID-19 death risk in women; key immune cells fail to respond to virus

The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus

Gilead targets remdesivir supply for two million COVID-19 patients by year-end

The company also said it hoped to start trials in August of an easier-to-use inhaled version of the medicine, currently administered only intravenously

Cipla to price remdesivir version for COVID-19 under 5,000 rupees

Cipla, in an e-mailed statement, did not provide details on when the treatment, called Cipremi, will be available

Merck to unveil its latest innovation during Live Virtual Launch on June 18

Redesigns its Benchtop Pure Water Solution - the Milli-Q? IX Pure Water Purification System

Britain may approve COVID-19 vaccine from Pfizer-BioNTech this week, reports Telegraph

The report also informs that the NHS had been told to be ready to administer it by December 1

Homegrown COVID-19 vaccine final trials may conclude within two months: India

ICMR and Bharat Biotech month started third-stage trials of COVAXIN, in a process that would involve 26,000 volunteers

Pfizer-BioNTech COVID-19 vaccine may create set of firsts for pharma sector: GlobalData

In modern history, no vaccine has ever been considered as essential to restoring normality to our way of life as these first mRNA vaccines, says analyst

ISMMS, Boehringer Ingelheim to test nintedanib for treating pulmonary fibrosis post-COVID-19 infection

The primary endpoint of the study is percent change in forced vital capacity, a measurement of lung function, compared to baseline over six months

India is a key market for us, it is a pharma centre of excellence

Alessandra Vizza, Regional Business Director, Corning Reactor Technologies talks about Advanced-Flow Reactors (AFR) and explains how it can help Indian pharma companies upscale their production output by providing continuous process production capacity of up to hundreds of kilograms per hour, the company's plans for the Indian market and more, in interaction with?Lakshmipriya Nair

COG-UK Consortium gets ?12.2 mn for COVID-19 genomic surveillance

Since its launch in March 2020, COG-UK has generated and made publicly available more than 100,000 SARS-CoV-2 genomes.

Indian pharma industry: Backbone of Indian economy in the current pandemic

Taruna Sondarva, Principal Consultant, IKON Marketing Consultants, outlines how the Indian pharma industry is contributing towards the health of our economy during the pandemic and opines that it will continue to be a growth driver in times to come?

Enabling IIOT solutions for Smart Pharma Packaging & Serialisation

The COVID-19 crisis is tantamount to a trial by fire for India Pharma Inc. And packaging has a crucial role in making the industry stronger and more resilient in the battle against the coronavirus pandemic. After all, it shares the responsibility of ensuring the safety and efficacy of medicines and other healthcare supplies until they reach those who need them the most.

Read More

Serum Institute starts manufacturing Codagenix's COVID-19 vaccine candidate

CDX-005, an intranasal, live-attenuated vaccine candidate, has completed preclinical animal studies, and Codagenix expects to initiate human trials by end of 2020

Samsung Biologics and AstraZeneca sign manufacturing deal for $330.8 million

Samsung Biologics will provide large-scale commercial manufacturing for drug substance in its Plant 3 as well as drug product to support AstraZeneca’s biologics therapeutics

Bayer gets DCGI nod for intravitreal aflibercept injection, Eylea to treat diabetic macular edema

Intravitreal Aflibercept is administered via injection directly in the area of swelling in the eye

SPARC signs license agreement with Tripoint Therapeutics for Elepsia XR tablets

SPARC will be eligible to receive tiered royalties ranging from 15 per cent to 50 per cent on net sales

ARCA biopharma submits IND application to US FDA for a potential COVID-19 treatment

Pending FDA feedback, ARCA anticipates initiating the Phase 2b portion of a sequential Phase 2b/3 clinical evaluation of AB201 in the fourth quarter of this year

Scientists find new drug that may be able to prevent or mitigate severe COVID-19 infection

Repurposing the 4-PBA anti-stress drug could modulate such cellular stress and curb mortality caused by respiratory failure derived from cellular stress, said researchers

Why COVID-19 presents a golden opportunity to Indian pharma firms

Juilee Dandekar, Sector Expert – Healthcare, Business Research & Advisory, Aranca informs that with India Pharma Inc’s expertise and cost competitiveness in manufacturing, it can play a major role in ensuring access to essential medicines and vaccines and has a great potential for growth

Vaccine delivery system should involve all levels of governments and citizen groups: PM Modi

He stressed that every step in the logistics, delivery, and administration should be put in place rigorously

Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size

For the past two decades, single-use disposable autoinjectors have become the predominant drug delivery device to treat immunosuppressive and inflammatory diseases, and a range of other health conditions. Autoinjectors have evolved to become more compact, reliable, and easy to use; however, these devices also possess certain suboptimal characteristics associated with single-use products. New innovations can now overcome the challenges of traditional disposable autoinjector technology, while providing a proven platform for pharmaceutical companies.

Read More

Remdesivir price curbs in India make COVID-19 treatment more affordable: GlobalData

Maharashtra has fixed the price of remdesivir at Rs 2,360, 16 per cent more economical than the cheapest brand Remdac at Rs 2,800 by Zydus Cadila and 56 per cent more economical than Covifor at Rs 5,400 by Hetero Labs

NAFDAC blacklists Gujarat pharma firm, Mars Remedies

The firm has been blacklisted by the Nigerian agency for allegedly manufacturing substandard and falsified Ciprofloxacin 500 mg tablets

Genentech announces full FDA approval for Venclexta combinations for acute myeloid leukaemia

The approval is primarily based on the results of two Phase III studies, VIALE-A and VIALE-C

Dr Reddy’s, RDIF get DCGI nod for Phase II/III clinical trials of COVID-19 vaccine Sputnik V in India

This will be a multicentre and randomised controlled study, which will include safety and immunogenicity study

Choosing the right type of desiccant is quintessential for your product's shelf life

CILICANT understands how critical it is to choose the right desiccant and offers a variety of sorbents developed for different applications

Serum Institute of India gets DCGI nod for phase 2 and 3 human trials of Oxford vaccine candidate

As per the study design, each subject will be administered two doses four weeks apart (first dose on day one and second dose on day 29) following which the safety and immunogenicity will be assessed at predefined intervals

Wockhardt signs partnership with UK Government to fill-finish COVID-19 vaccine

The manufacturing will be undertaken at CP Pharmaceuticals, a subsidiary of Wockhardt based in Wrexham, North Wales

Pharma industry seeks financial assistance from government for rare diseases

National level pharma associations organised a virtual meeting to discuss challenges, opportunities in this segment

Jubilant Life Sciences launches JUBI-R for COVID-19 treatment

The company will make the drug available to over 1,000 hospitals providing COVID-19 treatment in India through its distribution network

Sun Pharma launches generic favipiravir, FluGuard at Rs 35 per tablet

The stocks of FluGuard will be available in the market from this week

Kokate Committee releases list of 471 rational FDCs?

DCGI allows SLAs to grant product licenses provided the defined pathways are followed

AbbVie, Amgen and Takeda jointly study impact of anti-inflammatory drugs in COVID-19 treatment

I-SPY COVID will evaluate the impact of cenicriviroc, otezla, and firazyr on inflammatory response in severely ill, hospitalised COVID-19 patients

Sanofi to acquire Principia Biopharma

The deal adds to Sanofi's R&D areas of autoimmune and allergic diseases

D&C Act 1940 should be reframed: Pharma stakeholders

It needs to be updated to suit the industry’s present scenario and growth prospects

Ipca Labs is setting up API manufacturing facility in Dewas, MP

It is in the process of procuring environmental clearance for the new plant which is being built with an initial capital outlay of about Rs 250 crores

Pharma-telehealth partnerships: Rules of the game?

Industry advisors outline the legal aspects that need to be considered and fulfilled as pharma and telehealth players get into strategic alliances with each other?

CARE consortium launched to fast-track discovery and development of medicines to treat COVID-19

The CARE consortium comprises 37 teams from academic and non-profit research institutions and pharma companies?

Race to find a viable vaccine: Can Indian firms rise to the challenge?

Juilee Dandekar, Sector Expert – Healthcare, Business Research & Advisory, Aranca gives an overview of India's capabilities to develop and manufacture vaccines?

India's CMO market is hotbed??? for global PE investment: GlobalData

Indian pharma companies are more likely to engage in contract/excess capacity API manufacture than companies in the other small molecule API hotspots such as in the US and China

DCGI queries pharma company on its claim of FabiFlu use for COVID-19 patients with comorbidities

As per statement by the Glenmark and media reports, the DCGI had accelerated the process for clinical trials and reviews considering the pandemic situation, unmet medical conditions and unavailability of specific therapeutic management against COVID-19 for this drug

Seven Indian pharmaceutical companies race to develop vaccine for deadly coronavirus

Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms working on the coronavirus vaccines in India

AIIMS Ethics Committee gives nod to human clinical trial of Covaxin

AIIMS-Delhi is among the 12 sites selected by the Indian Council for Medical Research (ICMR) for conducting phase I and II human trials of Covaxin The AIIMS Ethics Committee gave its nod for a human clinical trial of the indigenously developed COVID-19 vaccine candidate Covaxin following which the premier hospital is likely to […]

Golden moment for India in key sectors including pharma over next 10 years: Venture capitalist

Indian ministers, key bureaucrats and technology industry leaders should put together a roadmap, set of regulations and authorisations so that companies can come in easily, says Silicon Valley entrepreneur and investor, MR Rangaswami

Arab Pharma Manufacturers’ Expo 2020 to be organised virtually in September

The most unique feature of the Arab Pharma Manufacturers’ Expo (Virtual Exhibition) is incorporation of a complete spectrum of more than 500 categories of the products / services under 18 sections to make the entire process of the visitor highly user friendly and product specific

AccelTRA Component Case Study: Reducing lead time and optimising cost

Use of the AccelTRA component platform - including components, extractables data and collaboration with West's technical experts - helped the customer realise significant savings, reduce elastomer SKU complexity and increase speed to market

Cipla and Roche partner up to improve access to oncology medicines

Roche and Cipla had previously entered into a similar agreement in February 2018 for promotion and distribution of Tocilizumab (Actemra) and other products

Double digit MCap growth in 2019 for 14 of top 20 pharma companies: GlobalData

Among the positive performances were Takeda Pharmaceutical and Daiichi Sankyo, which reported more than 100 per cent YoY growth in their market caps

IIT Alumni Council to partner with ICT Mumbai for MegaLab

ICT Mumbai has now become the second institutional partner in the MegaLab initiative after Mumbai University

Distilleries to get six-month extension to manufacture hand sanitisers

The fixed retail prices of hand sanitisers will also continue up to December 31, 2020

Safe and effective vaccination should be given high priority: EMA

The two ICMRA statements aim to reassure healthcare professionals and the public around the globe that medicines regulators only allow vaccines onto the market that fulfil the highest standards of safety, efficacy and quality

Bangladesh launches clinical trial of two-drug combination to treat COVID-19

Reportedly, the combination of anti-parasitic medicine Ivermectin and antibiotic doxycycline cured all the 60 COVID-19 patients within days

Merck to unveil its latest innovation during Live Virtual Launch on June 18

Redesigns its Benchtop Pure Water Solution - the Milli-Q? IX Pure Water Purification System

Understanding Virus and Viral Vaccine Development Using Multi Spectral Advanced Nano-Tracking Analyzer (NTA)

By Dr. Namrata Jain, Kanika Thakur, Dr. Jeffrey Bodycomb, Dr. Rajeev Gautam, Dr. John Kiran Anthony

GAVI's new drive for COVID-19 vaccine access in LMIC countries includes India

The list of 92 AMC-eligible economies includes all economies with GNI per capita under $4,000 plus other World Bank International Development Association eligible economies

Sanofi, GSK to supply 100 mn doses of COVID-19 vaccine to US, in talks with EU for 300 mn doses

The deal is worth $2.1 billion and involves the supply of vaccines for 50 million people, with the option to buy another 500 million doses

Govt mulls QR code implementation in domestic pharma market, industry cites challenges

Limitations of available technology, cost of investment, and impact on the cost of drugs, need for validation of technology through small trials and the time window for implementation were highlighted by pharma stakeholders

Biocon Biologics to get Rs 225 cr from Tata Capital Growth Fund for 0.85 per cent equity stake

Post the completion of this transaction, Biocon will hold 95.25 per cent stake in Biocon Biologics

US FDA grants Breakthrough Therapy Designation for Takeda's Pevonedistat

The investigational drug is for the treatment of patients with higher-risk myelodysplastic syndromes (HR-MDS)

Boehringer Ingelheim expands animal health portfolio in India market with two new drugs launches

NexGard and Broadline provide comprehensive parasite treatment for companion animals

Serum Institute says in active talks with Indian government around potential COVID-19 vaccines

Serum Institute has partnered with global players including AstraZeneca and Novavax Inc to run domestic trials on their vaccine candidates and produce the vaccines if they secure approvals.

Expect to commercialise vaccine facility by April-May 2021: Aurobindo Pharma

It is investing around Rs 275 crores on the facility to produce vaccines for the treatment of various viral diseases including COVID-19

Govt extends validity of import licence & registration certificate by six months

The order will be valid for a period of six months from the date of its publication in the Official Gazette.

China has highest PD-1/PD-L1 combination immuno-oncology therapies clinical trials growth: GlobalData

Between 2017 and 2019, the number of clinical trials initiated for PD-1/PD-L1 targeted combination therapies increased substantially, which continued in 2020, albeit with a significantly slower rate possibly due to the global COVID-19 pandemic

PLI Schemes for bulk drugs and medical devices receives encouraging response

The PLI Scheme for Bulk Drugs and for Medical Devices was approved by the Government on March 20, 2020

Covid-19 vaccine distribution- A daunting task, but there is a way out

The unprecedented pandemic and the havoc wrecked by COVID-19 have brought the leaders of scientific community all over the world together and the sharpest of the minds have been relentlessly working towards a solution to address this. A unique Global initiative -COVAX, with 172 countries joining hands has the world's largest and the […]

Dr Reddy's to acquire select anti-allergy brands from Glenmark in Russia and other CIS countries

The acquired brands represent two types of products, mometasone mono product and combination of mometasone with azelastine.

Potential COVID-19 vaccine not ‘single solution’ to pandemic, Johnson & Johnson CEO says

Gorsky said it was a good thing other companies are experimenting with different approaches to vaccines, in part because different vaccines might work better in different groups of people

Cipla launches Cipremi, likely to price it Rs 4,000 per vial

It is looking to supply over 80,000 vials within the first month

Pharma firms initiate steps to curb black marketing of remedisivir

Measures include constant monitoring of the drug's usage and ensuring its uninterrupted supply by working in collaboration with healthcare practitioners and regulators

Premas Biotech initiates triple antigen VLP COVID-19 vaccine candidate for animal trials

At the moment, it is the only one from India to adopt a triple-antigen approach that is designed to produce an enhanced immune response.

Blueprint for self-reliance in the bio-pharma sector

Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals highlights that the COVID-19 crisis has opened a window of opportunity for the biopharma sector to showcase its potential to provide viable and superior alternatives to APIs and synthetic drugs used within the pharma industry, and even deliver options for products such as antibiotics to deliver more holistic health outcomes

Takeda launches IBD medication Kynteles in India

Used to treat ulcerative colitis and Crohn’s Disease as well, the drug expands the company's GI portfolio in the country ?

World's first phase III clinical trial of COVID-19 inactivated vaccine begins in UAE

H.E. Sheikh Abdullah bin Mohammed Al Hamed, Chairman of Department of Health, Abu Dhabi is the first to participate in the vaccination trial

Greater global cooperation needed to tackle vaccine-preventable diseases in a world with COVID-19

The study included researchers from the University of Strathclyde, University of Ghana, Imperial College London, the Center for Global Development Europe, London School of Hygiene & Tropical Medicine and the University of Cambridge and is funded by the UK Government and the Bill & Melinda Gates Foundation

US FDA working to restart on-site inspections during week of July 20

The FDA, which is working towards resuming on-site inspections around July 20, also determined that, for the foreseeable future, prioritized domestic inspections will be pre-announced to FDA-regulated businesses

Cadila Pharma launches drug for treatment of Vulvovaginal Candidiasis

Fenticad will be made available in 600 mg tablets

Positive news on Oxford/AstraZeneca COVID-19 vaccine could come soon: ITV

The project has started Phase III of the human trials to assess how the vaccine works in a large number of people over the age of 18, but has yet to report Phase I trial results

Arab Pharma Manufacturers’ Expo 2020 to be organised virtually in September

The most unique feature of the Arab Pharma Manufacturers’ Expo (Virtual Exhibition) is incorporation of a complete spectrum of more than 500 categories of the products / services under 18 sections to make the entire process of the visitor highly user friendly and product specific

Government-funded Centre for Biopharma Analysis set up in Pune

It has numerous high-end instrumentation facilities worth Rs 10 crore and is expected to fast track research under biopharma in the country

NPPA issues final guidelines to discontinue making medicines under price control

The NPPA website will be uploading the list of applications filed by pharma companies and approved by the competent authority for discontinuation

Why active packaging plays such an important role in the pharmaceutical industry

Active packaging protects pharmaceuticals and other medical supplies from oxygen and moisture, thereby playing an important role in ensuring that they are effective and completely safe for patient usage.

Biological E signs tech transfer pacts with Baylor College of Medicine and J&J for COVID-19 vaccine

The agreements are for Baylor’s recombinant protein vaccine candidate and J&J’s Ad26.COV2.S vaccine, currently in Phase 1/2 clinical trials

Amazon India launches online pharmacy services in Bengaluru

It may be scaled up to other cities in the future

Russia begins production of COVID-19 vaccine

It would be producing about five million doses a month by December-January, Interfax said

Lupin presents Phase 3 data for Solosec in female patients with trichomoniasis

The company plans to submit a supplemental New Drug Application for Solosec to the FDA for the treatment of trichomoniasis later this year

World's first phase III clinical trial of COVID-19 inactivated vaccine begins in UAE

H.E. Sheikh Abdullah bin Mohammed Al Hamed, Chairman of Department of Health, Abu Dhabi is the first to participate in the vaccination trial

Greater global cooperation needed to tackle vaccine-preventable diseases in a world with COVID-19

The study included researchers from the University of Strathclyde, University of Ghana, Imperial College London, the Center for Global Development Europe, London School of Hygiene & Tropical Medicine and the University of Cambridge and is funded by the UK Government and the Bill & Melinda Gates Foundation

US FDA working to restart on-site inspections during week of July 20

The FDA, which is working towards resuming on-site inspections around July 20, also determined that, for the foreseeable future, prioritized domestic inspections will be pre-announced to FDA-regulated businesses

Cadila Pharma launches drug for treatment of Vulvovaginal Candidiasis

Fenticad will be made available in 600 mg tablets

Positive news on Oxford/AstraZeneca COVID-19 vaccine could come soon: ITV

The project has started Phase III of the human trials to assess how the vaccine works in a large number of people over the age of 18, but has yet to report Phase I trial results

Moderna Phase 1 results show coronavirus vaccine safe, induces immune response

Volunteers who got two doses of the vaccine had high levels of virus-killing antibodies that exceeded the average levels seen in people who had recovered from COVID-19: Moderna’s research team

Blue Dart strengthens its temperature controlled logistics solution for supply of COVID-19 vaccine

Blue Dart is ramping up its infrastructure with its pre-existing specialised Temperature Controlled Logistics (TCL) to combat the pandemic. The company will further offer complete Supply Chain Solution for the Life Sciences and Clinical Trials Sector and reefer vehicles (cold chain) services to the vaccine sector to ensure seamless transport of shipments. As […]

Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size

For the past two decades, single-use disposable autoinjectors have become the predominant drug delivery device to treat immunosuppressive and inflammatory diseases, and a range of other health conditions. Autoinjectors have evolved to become more compact, reliable, and easy to use; however, these devices also possess certain suboptimal characteristics associated with single-use products. New innovations can now overcome the challenges of traditional disposable autoinjector technology, while providing a proven platform for pharmaceutical companies. Join this webinar and learn: + Why disposable, single-use autoinjectors, introduced in the early 2000s, can no longer satisfy today's requirements to reduce space, storage, and waste + The growing demand for drug delivery device connectivity to improve patient adherence, care team collaboration, and health outcomes + How pharmaceutical companies can create a clear path to low-cost connectivity with more affordable, convenient, and sustainable injection devices + Examples of smart, reusable, autoinjectors that work with mobile apps to track and transmit digital data from patients to physicians + Key considerations when embracing a connected health platform for biologic and injectable drugs Speakers: + Kevin Deane, Vice President - Front-End Innovation and Connected Health Phillips-Medisize + Vivek Malhotra, Director Sales, Asia Phillips-Medisize

Read More

Marksans Pharma and Sun Pharma voluntarily recall metformin

oth the companies are recalling metformin because it may contain N-nitrosodimethylamine (NDMA) above the acceptable intake limit.

Piramal Pharma announces completion of 20 per cent strategic growth investment by Carlyle

This transaction is one of the largest private equity deals in the Indian pharmaceutical sector. It provides Piramal Pharma growth capital that enables it to invest in accelerated business growth through both organic and inorganic opportunities

Choosing the right type of desiccant is quintessential for your product's shelf life

CILICANT understands how critical it is to choose the right desiccant and offers a variety of sorbents developed for different applications

NVIDIA partners with GSK's AI-powered lab for discovery of medicines and vaccines

NVIDIA will contribute its deep expertise in GPU optimisation and high-performance computational pipeline development, including NVIDIA Clara Discovery, a new collection of optimised computational drug discovery applications and frameworks

Digital adoption by pharma manufacturers

Inderpreet Kambo, Associate Director and Jeremy Carter, Senior Director at Axtria explain how data analytics has now become main-stream within the pharma-biotech space as companies, payers, and regulators attempt to store data and make data-driven decisions

India prepares for 600 mn COVID vaccine shots; to use standard cold storage: VK Paul

Serum, Bharat, Zydus, and Sputnik need normal cold chain. I see no problem for these vaccines, he said

IPA to train 10 lakh pharmacists for COVID-19 vaccinations

The association has asked its 22 state branches to identify five thousand registered pharmacists each for training with an aim to create a national-level database of potential COVID-19 vaccinators

AstraZeneca to acquire Alexion

Subject to approvals, the acquisition is expected to close in Q3 2021

Cipla settles patent litigation of Revlimid (lenalidomide) capsules with Celgene

Celgene has agreed to provide Cipla with a license to Celgene's patents required to manufacture and sell certain volume-limited amounts of generic lenalidomide in the US beginning on a confidential date that is some time after March 2022

New therapies will overcome unmet needs in hepatocellular carcinoma: GlobalData

They have different mechanisms of action and are aiming to meet needs in different treatment settings

Social media research helps in product benchmarking and brand communication analysis

Dr Ranjit Nair, CEO,?Germin8, explains the emerging role of social media platforms in providing digital intelligence to pharma companies. He also explains how his company is helping pharma companies to understand market requirements with solutions for social media listening and analysis, in an interview with?Usha Sharma

Pharmacovigilance during a pandemic

John Danese, Industry Director, Life Sciences, Birlasoft; Sreenivas Reddy N, Global Program Director, Life Sciences, Birlasoft explain that legacy pharmacovigilance workflows and systems need a massive overhaul to ensure organisational efficiency and reduce the cost of compliance, especially during a pandemic

Serum India, Bharat Biotech to test intranasal COVID-19 vaccines post regulatory nod: Dr Harsh Vardhan

He clarified that Phase III clinical trial is generally with thousands of participants, sometimes even close to 30,000 to 40,000 participants

Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size

For the past two decades, single-use disposable autoinjectors have become the predominant drug delivery device to treat immunosuppressive and inflammatory diseases, and a range of other health conditions. Autoinjectors have evolved to become more compact, reliable, and easy to use; however, these devices also possess certain suboptimal characteristics associated with single-use products. New innovations can now overcome the challenges of traditional disposable autoinjector technology, while providing a proven platform for pharmaceutical companies.

Read More

DPX-COVID-19 has potential to improve duration of immune response

Frederic Ors, CEO, IMV explains why the company believes that?DPX-COVID-19 has the potential to improve the duration of the immune response and protect older?adults and more vulnerable individuals from SARS-COV-2 infection, in an interaction with?Viveka Roychowdhury ?

First results of Russian coronavirus vaccine trial may include data from 5,000-10,000 people

Preliminary results from the late-stage human trial of Russia's main coronavirus vaccine candidate could include data from 5,000-10,000 participants, Denis Logunov, a director at the Gamaleya Institute that developed the vaccine, said on Monday. Russia's plan to publish preliminary data about the Sputnik V jab as early as November is likely to make […]

Choosing the right type of desiccant is quintessential for your product's shelf life

CILICANT understands how critical it is to choose the right desiccant and offers a variety of sorbents developed for different applications

BDR Pharma launches Nintenib (Nintedanib) to treat idiopathic pulmonary fibrosis in India

Nintenib is priced at Rs 750 (100 mg) and INR 900 (150 mg) for a pack of 10 tabs

Mental Health: A challenge and an opportunity

On Mental Health Day, Jayasree K Iyer, Executive Director, Access to Medicine Foundation highlights that mental health should be prioritised as a development issue to solve a major public health challenge and ensure that it remains attractive for investment